Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-08-18

Clinical Trial Update: Evaluating the Effect of Cromolyn Sodium in Uremic Pruritus [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating cromolyn sodium for uremic pruritus in patients with end-stage renal disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cromolyn Sodium (Cromolyn Sodium)

Snippet

Sponsor: Shiraz University of Medical Sciences | Conditions: End Stage Renal Disease, Pruritus | Phase 2 | Status: COMPLETED